whether Pradax (dabigatran) will replace warfarin in patients with atrial fibrillation

October 2009

Experts are debating whether Pradax (dabigatran) will replace warfarin in patients with atrial fibrillation.

Pradax is an ORAL direct thrombin inhibitor. It's used to prevent venous thrombosis after hip or knee replacement surgery.

Now a big study in the New England Journal of Medicine shows that Pradax works at least as well as warfarin for preventing strokes in patients with atrial fibrillation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Influenza using antivirals and vaccines for the current flu season
computer alert about possible serotonin syndrome when patients get more than one serotonergic drug
Respiratory & Allergy Symbicort (budesonide/formoterol) will be used more for COPD
Diabetes questions about how to switch between insulins
Psychiatry Abilify (a-BILA-fi), a new atypical antipsychotic for schizophrenia and bipolar disorder
Women's Health You'll hear more about limiting antidepressants during pregnancy
Women's Health whether Yaz and Yasmin (drospirenone/ethinyl estradiol) are riskier than other combined oral contraceptives
Cimzia (CIM-zee-uh) for rheumatoid arthritis
Cardiology whether Pradax (dabigatran) will replace warfarin in patients with atrial fibrillation
Cardiology whether a DOUBLE dose of clopidogrel (Plavix) improves outcomes in cardiac patients
Statins questions about resolving statin myopathy
Infectious Diseases new vaccine to prevent shingles called Zostavax

whether Pradax (dabigatran) will replace warfarin in patients with atrial fibrillation

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents